Long-term clinical outcomes of gastric mucosa-associated lymphoid tissue lymphoma in real-world experience
Authors:
Open Access
- 25 February 2023
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (4) , 877-888
Abstract
This long-term, retrospective, single-center study evaluated real-world clinical outcomes of gastric mucosa-associated lymphoid tissue (MALT) lymphoma using different therapeutic modalities and analyzed factors affecting survival outcomes and long-term prognosis. We enrolled 203 patients with pathologically confirmed low-grade gastric MALT lymphoma and examined their treatment responses. Helicobacter pylori eradication was performed in all patients with H. pylori infection (HPI) and localized stage gastric MALT lymphoma. All patients underwent pre-treatment and physical evaluations, with complete blood count, biochemistry panel, and staging workup. Among 144 HPI-positive patients with stage I or II1–2 disease who underwent H. pylori eradication, 112 (77.8%) achieved complete remission (CR). All HPI-negative patients who received first-line radiotherapy achieved CR (100%), but only 22 of 27 first-line chemotherapy-treated patients achieved CR (81.5%). Lesions in the proximal upper-third or in multiple locations and an invasion depth to the submucosa or deeper were associated with poor response to eradication, and HPI negativity was significantly correlated with poor progression-free survival. HPI eradication treatment should be the first-line treatment for patients with localized stage HPI-positive gastric MALT lymphoma. The “watch-and-wait” strategy should be adopted for delayed responders. We suggest radiotherapy for patients with a localized HPI-negative status or when eradication has failed.Keywords
This publication has 24 references indexed in Scilit:
- Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized StudyJournal of Clinical Oncology, 2013
- Pathophysiology of Gastric MALT LymphomaThe Korean Journal of Medicine, 2012
- EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALTGut, 2011
- Molecular Aspects ofH. pylori-Related MALT LymphomaPathology Research International, 2011
- Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT typeAnnals of Oncology, 2009
- Wotherspoon criteria combined with B cell clonality analysis by advanced polymerase chain reaction technology discriminates covert gastric marginal zone lymphoma from chronic gastritisGut, 2006
- Gastrointestinal lymphoma: where morphology meets molecular biologyThe Journal of Pathology, 2005
- High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphomaBlood, 2002
- The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pyloriThe Lancet, 1993
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993